Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
28 Oktober 2024 - 9:30PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
For
the month of October 2024
Commission
File Number: 001-40614
INTERCURE
LTD.
(Translation
of registrant’s name into English)
85
Medinat ha-Yehudim Street
Herzliya,
4676670, Israel
Tel:
+972 77 460 5012
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
On
October 28, 2024, InterCure Ltd. (the “Company”) convened an Extraordinary General Meeting of Shareholders (the “Extraordinary
General Meeting”). However, the Extraordinary General Meeting was adjourned for one week to the same day, time and place due to
lack of quorum. Accordingly, the Company’s Extraordinary General Meeting will be reconvened on Monday, November 4, 2024 at 4:00
p.m., Israel time, at the offices of the Company’s attorneys, Doron Tikotzky Kantor Gutman & Amit Gross, at 7 Metsada St.,
B.S.R Tower 4, Bnei Brak, Israel.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| |
INTERCURE
LTD. |
| |
|
| Date:
October 28, 2024 |
/s/
Amos Cohen |
| |
Amos
Cohen
|
| |
Chief
Financial Officer |
Intercure (NASDAQ:INCR)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Intercure (NASDAQ:INCR)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
